Literature DB >> 15310708

Long term persistence with statin treatment in daily medical practice.

A K Mantel-Teeuwisse, W G Goettsch, O H Klungel, A de Boer, R M C Herings.   

Abstract

Mesh:

Substances:

Year:  2004        PMID: 15310708      PMCID: PMC1768444          DOI: 10.1136/hrt.2003.026187

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  5 in total

Review 1.  Current perspectives on statins.

Authors:  D J Maron; S Fazio; M F Linton
Journal:  Circulation       Date:  2000-01-18       Impact factor: 29.690

2.  Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials.

Authors:  J C LaRosa; J He; S Vupputuri
Journal:  JAMA       Date:  1999 Dec 22-29       Impact factor: 56.272

3.  Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials.

Authors:  M Pignone; C Phillips; C Mulrow
Journal:  BMJ       Date:  2000-10-21

4.  Adherence with statin therapy in elderly patients with and without acute coronary syndromes.

Authors:  Cynthia A Jackevicius; Muhammad Mamdani; Jack V Tu
Journal:  JAMA       Date:  2002 Jul 24-31       Impact factor: 56.272

5.  Long-term persistence in use of statin therapy in elderly patients.

Authors:  Joshua S Benner; Robert J Glynn; Helen Mogun; Peter J Neumann; Milton C Weinstein; Jerry Avorn
Journal:  JAMA       Date:  2002 Jul 24-31       Impact factor: 56.272

  5 in total
  19 in total

1.  Functional foods: the case for closer evaluation.

Authors:  Nynke de Jong; Olaf H Klungel; Hans Verhagen; Marion C J Wolfs; Marga C Ocké; Hubert G M Leufkens
Journal:  BMJ       Date:  2007-05-19

Review 2.  Revisiting Rose: strategies for reducing coronary heart disease.

Authors:  Douglas G Manuel; Jenny Lim; Peter Tanuseputro; Geoffrey M Anderson; David A Alter; Andreas Laupacis; Cameron A Mustard
Journal:  BMJ       Date:  2006-03-18

3.  Dynamics of long-term statin therapy.

Authors:  Maarit Jaana Korhonen; Arja Helin-Salmivaara; Risto Huupponen
Journal:  Eur J Clin Pharmacol       Date:  2011-03-16       Impact factor: 2.953

4.  Statin adherence and the risk of major coronary events in patients with diabetes: a nested case-control study.

Authors:  Päivi Ruokoniemi; Maarit J Korhonen; Arja Helin-Salmivaara; Piia Lavikainen; Antti Jula; Seppo Y T Junnila; Raimo Kettunen; Risto Huupponen
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335

5.  Reasons for and time to discontinuation of rimonabant therapy: a modified prescription-event monitoring study.

Authors:  Marjolein J C Willemen; Aukje K Mantel-Teeuwisse; Yvonne Buggy; Deborah Layton; Sabine M J M Straus; Hubert G M Leufkens; Toine C G Egberts
Journal:  Drug Saf       Date:  2012-12-01       Impact factor: 5.606

6.  An economic evaluation of atorvastatin for primary prevention of cardiovascular events in type 2 diabetes.

Authors:  Scott D Ramsey; Lauren D Clarke; Craig S Roberts; Sean D Sullivan; Scott J Johnson; Larry Z Liu
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

7.  Persistence profile to nucleos(t)ide analogue treatment for patients with chronic hepatitis B.

Authors:  Yolanda Borrego Izquierdo; Encarnación Gómez Fernández; Patricia Monje Agudo; Rocío Jiménez Galán; Carmen V Almeida-González; Mónica Ferrit Martín; Ramón Morillo Verdugo
Journal:  Eur J Hosp Pharm       Date:  2016-02-22

8.  Promoting knowledge of statins in patients with low health literacy using an audio booklet.

Authors:  J Travis Gossey; Simon N Whitney; Michael A Crouch; Maria L Jibaja-Weiss; Hong Zhang; Robert J Volk
Journal:  Patient Prefer Adherence       Date:  2011-08-10       Impact factor: 2.711

9.  Why have total cholesterol levels declined in most developed countries?

Authors:  Simon Capewell; Earl S Ford
Journal:  BMC Public Health       Date:  2011-08-11       Impact factor: 3.295

10.  Adherence to lipid-lowering treatment: the patient perspective.

Authors:  Manuela Casula; Elena Tragni; Alberico Luigi Catapano
Journal:  Patient Prefer Adherence       Date:  2012-11-08       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.